Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT02070458 · COMPLETED
Trial details
- NCT number
- NCT02070458
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-08
- Primary completion
- 2017-03-17
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.